Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Zydus Lifesciences Limited
November 4, 2025
Zydus Lifesciences Limited
Orphan Drug Designation
FDA orphan drug designation: treatment of beta-thalassemia
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
